Open Access

MicroRNA‑505‑3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression

  • Authors:
    • Zhenlin Cheng
    • Bin Wang
    • Cheng Zhang
  • View Affiliations

  • Published online on: June 9, 2020     https://doi.org/10.3892/ol.2020.11714
  • Pages: 1663-1670
  • Copyright: © Cheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previous studies have reported that microRNA (miR)‑505 exhibits important effect in human cancers. However, the regulatory mechanism of miR‑505‑3p/high‑mobility group box 1 (HMGB1) axis is still unclear in glioma. Therefore, the regulatory mechanism of miR‑505‑3p/HMGB1 axis in glioma was illuminated. Expression of miR‑505‑3p and HMGB1 was observed by RT‑qPCR. Protein expression was measured by western blot analysis. Dual luciferase assay was performed to confirm the relationship between miR‑505‑3p and HMGB1. The function of miR‑505‑3p was investigated by MTT and Transwell assays. Expression of miR‑505‑3p was reduced in glioma, which was related to poor clinical outcomes and prognosis in glioma patients. Moreover, overexpression of miR‑505‑3p suppressed proliferation, migration and invasion of glioma cells. In addition, HMGB1 was confirmed as a direct target of miR‑505‑3p, and miR‑505‑3p inhibited the development of glioma by targeting HMGB1. Furthermore, miR‑505‑3p blocked EMT suppressing p‑AKT expression in glioma cells. In conclusion, miR‑505‑3p inhibited the development of glioma by targeting HMGB1 and regulating AKT expression.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Cheng, Z., Wang, B., & Zhang, C. (2020). MicroRNA‑505‑3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression. Oncology Letters, 20, 1663-1670. https://doi.org/10.3892/ol.2020.11714
MLA
Cheng, Z., Wang, B., Zhang, C."MicroRNA‑505‑3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression". Oncology Letters 20.2 (2020): 1663-1670.
Chicago
Cheng, Z., Wang, B., Zhang, C."MicroRNA‑505‑3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression". Oncology Letters 20, no. 2 (2020): 1663-1670. https://doi.org/10.3892/ol.2020.11714